Table 5: Reported Adverse Drug Reactions of Omalizumab

Table 5. Reported Adverse Drug Reactions of Omalizumab

System	Adverse Reactions
Respiratory	Pharyngitis, upper respiratory tract infection, sinusitis, pneumonia, asthma exacerbation
CNS	Fatigue, pain, headache, dizziness
Local	Injection site reactions (swelling, redness)
Dermatologic	Pruritus, dermatitis, urticaria, rash
Musculoskeletal	Leg pain, fracture, arm pain, arthralgia
Gastrointestinal	Vomiting, gastroenteritis, diarrhea
Otic	Earache
Miscellaneous	Anaphylaxis, malignancy, eye edema, rhinitis

Adapted from: Lexi-Drugs® online. Omalizumab monograph. Accessed 14 August 2003.
Omalizumab package insert. 1 DNA Way, CA:Genentech Inc.; June 2003.
Food and Drug Administration Center for Biologics Evaluation and Research. Briefing document on safety BLA STN 103976/0 Rockville, MD: The Department of Health & Human Services; 2003.

Click Here to Return to Article